Skip to main content

Features

Kristi Hawley, DO, FAAD
After receiving calls from a few colleagues, Dr Kristi Hawley decided it was time to address a number of the questions being asked regarding psoriasis and COVID-19.
Cynthia Griffith, MPAS, PA-C
How have practices changed? A physician assistant offers a look into how her facility adjusted to the pandemic and how she kept up with the latest in evidence-based dermatology.
Steven A. Davis, MD
While surgery is still the treatment of choice for cutaneous malignancy, newer technologies such as surface radiotherapy can provide an alternative for patients with nonmelanoma skin cancers.
Lauren Melnick, BS, Chloe Silva, BS, Robin Lewallen, MD, FAAD
After a year of battling the modern pandemic, we are now seeing a mass roll-out of one of our best weapons against COVID-19: vaccines. While mRNA technology is novel, it is an effective tool in the fight against COVID-19 with several unique considerations for dermatology.
Lauren Mateja, Managing Editor
The newly created Society of Dermatology Nurse Practitioners looks to unify the voice of nurse practitioners practicing in the dermatology space alongside physician and physician assistant colleagues.
Lauren Mateja, Managing Editor
Hair can be intimidating to treat and frustrating for patients, but Dr Matt Leavitt offers some easy pearls to drop into any medical dermatology practice.
Vassiliki Papastavros, MD, Pavan K. Nootheti, MD, FAAD, FACMS
The authors discuss a case report of a rare malignancy only discovered upon Mohs surgery, highlighting the importance of examining the entire tissue specimen on histology.
Varun Ranpariya, BA, Deborah Cull, BSE, Steven R. Feldman MD, PhD, Lindsay C. Strowd, MD
New guidelines for the documentation of evaluation and management take effect January 1, 2021, and coding changes may affect payments in outpatient practices.
Christopher White, DO, Tesia Kolodziejczyk, BA, Kristin Witfill, DO
While uncommon, the diagnosis and treatment of cutaneous adnexal tumors such as spiradenocarcinoma are incredibly important for prognostic implications.
Peter Sonnenreich, Mary Anne Dunkin
In this second article of a two-part series on androgenetic alopecia, physicians who treat hair loss discuss medication treatments and the factors that determine their choices.
Back to Top